Zengshu Xing
Haikou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Inverted V-shaped association between atherogenic index of plasma and kidney stone risk: results from NHANES 2011-2018.
Journal: Translational andrology and urology
Published: October 24, 2024
Predictive power of lipid-related indicators for testosterone deficiency: a comparative analysis, NHANES 2011-2016.
Journal: International urology and nephrology
Published: November 14, 2023
Targeting HOXA11-AS to mitigate prostate cancer via the glycolytic metabolism: In vitro and in vivo.
Targeting HOXA11-AS to mitigate prostate cancer via the glycolytic metabolism: In vitro and in vivo.
Journal: Journal of cellular and molecular medicine
Published: August 15, 2023
Association of TyG index with prostate-specific antigen (PSA) in American men: results from NHANES, 2003-2010.
Journal: Irish journal of medical science
Published: May 20, 2023
Comprehensive analysis of the importance of PLAUR in the progression and immune microenvironment of renal clear cell carcinoma.
Journal: PloS one
Published: September 15, 2021
Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: July 24, 2021
CircSERPINA3 regulates SERPINA3-mediated apoptosis, autophagy and aerobic glycolysis of prostate cancer cells by competitively binding to MiR-653-5p and recruiting BUD13.
Journal: Journal of translational medicine
Published: April 06, 2021
CTCF-induced upregulation of HOXA11-AS facilitates cell proliferation and migration by targeting miR-518b/ACTN4 axis in prostate cancer.
Journal: The Prostate
Published: November 04, 2019
The long non-coding RNA LINC00473 contributes to cell proliferation via JAK-STAT3 signaling pathway by regulating miR-195-5p/SEPT2 axis in prostate cancer.
Journal: Bioscience reports
Published: June 04, 2019
Tyrosine receptor kinase B silencing inhibits anoikis‑resistance and improves anticancer efficiency of sorafenib in human renal cancer cells.
Journal: International journal of oncology
Published: October 29, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026